Jeffrey W. Albers Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Jeffrey W. Albers is of Blueprint Medicines Corp. Currently has a direct ownership of 152,396 shares of BPMC, which is worth approximately $14.2 Million. The most recent transaction as insider was on Nov 16, 2020, when has been sold 20,000 shares (Common Stock) at a price of $8.8 per share, resulting in proceeds of $176,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 152K
3.28% 3M change
13.44% 12M change
Total Value Held $14.2 Million

Jeffrey W. Albers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
BUY
Exercise of conversion of derivative security
$176,000 $8.8 p/Share
20,000 Added 11.02%
161,434 Common Stock
Oct 07 2020
SELL
Open market or private sale
$495,850 $99.17 p/Share
5,000 Reduced 3.41%
141,434 Common Stock
Oct 07 2020
BUY
Exercise of conversion of derivative security
$44,000 $8.8 p/Share
5,000 Added 3.3%
146,434 Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
Director
KYMR
Kymera Therapeutics, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
JWA

Jeffrey W. Albers

Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC